Peter Gabriel

University of Pennsylvania

Papers

1

Total Citations

48

H-Index

1

About

Peter Gabriel is a leading clinical researcher in radiation oncology, with a focused expertise in head and neck cancers and the comparative effectiveness of advanced radiation modalities. His major contributions center on improving patient quality of life (QOL) by rigorously comparing conventional photon radiation therapy with proton beam therapy, particularly for oropharyngeal squamous cell carcinoma. His highly cited 2018 study, with 48 citations, demonstrated that pencil beam scanning proton therapy significantly spares normal tissues, leading to measurable QOL improvements for postoperative patients. This work has helped establish proton therapy as a viable, patient-centered alternative in a field where treatment toxicity is a major concern. Gabriel’s research bridges the gap between technological innovation and tangible patient outcomes, influencing clinical decision-making and treatment guidelines. His findings are especially valuable for students and researchers interested in the intersection of medical physics, survivorship, and evidence-based oncology. By quantifying the real-world benefits of proton therapy, Peter Gabriel has become a key voice in the ongoing effort to personalize and humanize cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer
48 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: University of Pennsylvania

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago